参考文献

[1]中华医学会器官移植分会.中国心脏死亡器官捐献工作指南（第2版）[J].中华器官移植杂志，2011，32（12）：756-758.

[2]国家卫生和计划生育委员会脑损伤质控评价中心.脑死亡判定标准与技术规范（成人质控版）[J/CD].中华移植杂志：电子版，2015，9（1）：13-17.

[3]国家卫生和计划生育委员会脑损伤质控评价中心.脑死亡判定标准与技术规范（儿童质控版）[J/CD].中华移植杂志：电子版，2015，9（2）：54-57.

[4]文宁，张素斌，秦科，等.早期目标液体复苏对脑死亡血流动力学及氧代谢的影响[J].广西医科大学学报，2011，28（5）：664-668.

[5]秦科，孙煦勇.体外膜肺氧合在心死亡或脑死亡捐献器官保护中的应用的进展[J].中华器官移植杂志，2012，33（11）：702-704.

[6]孙煦勇，秦科，董建辉，等.体外膜肺氧合对循环功能不稳定中国一类捐献器官功能的保护三例[J].中华器官移植杂志，2012，33（11）：657-660.

[7]霍枫，李鹏，汪邵平.体外膜肺氧合在心脏死亡器官捐献中的应用[J].中华消化外科杂志，2013，12（9）：648-651.

[8]蓝倩，李壮江，孙煦勇，等.体外膜肺氧合应用在捐献器官移植中的伦理学意义[J].中国医学伦理学，2015，28（5）：741-744.

[9]Mascia L，Mastromauro I，Viberti S，et al.Management to optimize organ procurement in brain dead donors[J].Minerva Anestesia，2009，75（3）：125-133.

[10]Guidelines relating to solid organ transplants from non-heart beating donors[DB/OL].British Transplantation Society，2004（2012）[2013-7-1].http//ukpmc.ac.uk/guidelines/HIR/142956.

[11]Council of Europe，European Directorate for the Quality of Medicine and HealthCare.Council of Europe：Guide to the quality and safety of organs for transplantation（5th edition）[M].Strasbourg，France，2013.

[12]Organ donation and transplantation activities 2011.Global Observatory on Donation and Transplantation[DB/OL].2011[2013-4-1].http//www.transplant-observatory.org/Pages/DataRepOrts.

[13]Matesanz R，Dominguez-Gil B，Coil E，et al.Spanish experience as a leading country：what kind of measures were taken？[J].Transplant Int，2011，24（4）：333-343.

[14]Barber K，Falvey S，Hamilton C，et al.Potential for organ donation in the United Kingdom：audit of intensive care records[J].Br Med J，2006，332（7550）：1124-1127.

[15]Sheehy E，O’Connor KJ，Luskina RS，et al.Investigating geographic variation in mortality in the context of organ donation[J].Am J Transplant，2012，12（6）：1598-1602.

[16]Dominguez-Gil，Delmonico F，Shaheen FAM，et al.The critical pathway for deceased donation：reportable uniformity in the approach to deceased donation[J].Transpl Int，2011，24（4）：373-378.

[17]De la Rosa G，Dominguez-Gil B，Matesanz R，et al.Continuous evaluating performance in deceased donation：The Spanish Quality Assurance Program[J].Am J Transplant，2012，12（9）：2507-2513.

[18]Procaccio F，Rizzato L，Ricci A，et al.Indicators of efficiency in potential organ donation and identification：preliminary results from the national registry of deaths with acute cerebral lessions in Italian intensive care units[J].Organ，Tissues and Cells，2008，2：125-129.

[19]Sheehy E，Conrad SL，Brigham LE，et al.Estimating the number of potential organ donors in the United States[J].N Engl J Med，2003，349（21）：667-674.

[20]Manara AR，Murphy PG，O’Callaghan G.Donation after circulatory death[J].J Anaesth，2012，108（Suppl 1）：i108-i121.

[21]Reich DJ，Mulligan DC，Abt PL，et al.ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation[J].Am J Transplant，2009，9（9）：2004-2011.

[22]Buell JF，Trofe J，Sethuraman G，et al.Donors with central nervous system malignancies：are they truly safe？[J].Transplantation，2003，76（2）：340-343.

[23]Merion RM，Ashby VB，Wolfe RA，et al.Deceased-donor characteristics and the survival benefit of kidney transplantation[J].JAMA，2005，294（21）：2726-2733.

[24]Olson L，Cravero L.Donor factors that affect the number of organs transplanted per donor[J].Prog Transplant，2009，19（3）：259-266.

[25]Halpern SD，Shaked A，Hasz RD，et al.Informing candidates for solid-organ transplantation about donor risk factors[J].N Engl J Med，2008，358（26）：2832-2837.

[26]Watson CJ，Johnson RJ，Birch R，et al.A simplified donor risk index for predicting outcome after deceased donor kidney transplantation[J].Transplantation，2012，93（3）：314-318.

[27]Singh RP，Farney AC，Rogers J，et al.Hypertension in standard criteria deceased donors is associated with inferior outcomes following kidney transplantation[J].Clin Transplant，2011，25（4）：E437-E446.

[28]Holmes B，Diamond M.Amyotrophic lateral sclerosis and organ donation：is there risk of disease transmission[J].Ann Neurology，2012，72（6）：832-836.

[29]Kauffman HM，McBride MA，Delmonico FL.First report of the United Network for Organ Sharing Transplant Tumor Registry：donors with a history of cancer[J].Transplantation，2000，70（12）：1747-1751.

[30]Desai R，Collett D，Watson CJ，et al.Cancer transmission from organ donors：unavoidable but low risk[J].Transplantation，2012，94（12）：1200-1207.

[31]Watson CJE，Roberts R，Wright KA，et al.How safe is it to transplant organs from deceased donors with primary intracranial malignancy？An analysis of UK Registry data[J].Am J Transplant，2010，10（6）：1437-1444.

[32]Mukhopadhyay P，Kumar V，Rathi M，et al.Transmission of human immunodeficiency virus infection by renal transplantation[J].Indian J Nephrol，2012，22（2）：133-135.

[33]Chiarelli AG.Donor and organ suitability：risk due to donor social behavior[J].Transplant Proc，2004，36（3）：426-427.

[34]McKeown DW，Bonser RS，Kellum JA.Management of the heartbeating brain-dead organ donor[J].Br J Anaesth，2012，108（Suppl 1）：i96-i107.

[35]Casartelli M，Bombardini T，Simion D，et al.Wait，treat and see：echocardiographic monitoring of brain-dead potential donors with stunned heart[J].Cardiovasc Ultrasound，2012，10（1）：1-8.

[36]Ballarin R，Cucchetti A，Spaggiari M，et al.Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors：a European multicentric case-control study[J].Transplantation，2011，91（11）：1265-1272.

[37]Seem DL，Lee I，Umscheid CA，et al.Excerpt from PHS guideline for reducing HIV，HBV and HCV transmission through organ transplantation[J].Am J Transplant，2013，13（8）：1953-1962.

[38]Rabinstein AA，Yee AH，Mangrekar J，et al.Prediction of potential for organ donation after cardiac death in patients in neurocritical state：a prospective observational study[J].Lancet Neurol，2012，11（5）：414-419.

[39]Power BM，Van Heerden PV.The physiological changes associated with brain death-current concepts and implications for treatment of the brain dead organ donor[J].Anaesth Intensive Care，1995，23（1）：26-36.

[40]Valero R.Donor management：one step forward[J].Am J Transplant，2002，2（8）：693-694.

[41]Mascia L，Mastromauro I，Viberti S，et al.Management to optimize organ procurement in brain dead donors[J].Minerva Anestesia，2009，75（3）：125-133.

[42]Venkateswaran RV，Patchell VB，Wilson IC，et al.Early donor management increases the retrieval rate of lungs for transplantation[J].Ann Thorac Surg，2008，85（1）：278-286.

[43]Cantin B，Kwok BW，Chan MC，et al.The impact of brain death on survival after heart transplantation：time is of the essence[J].Transplantation，2003，76（9）：1275-1279.

[44]Odim J，Laks H，Banedi A，et al.Does duration of donor brain injury affect outcome after orthotopic pediatric heart transplantation？[J].J Thorac Cardiovasc Surg，2005，130（1）：187-193.

[45]Abdelnour T，Rieke S.Relationship of hormonal resuscitation therapy and central venous pressure on increasing organs for transplant[J].J Heart Lung Transplant，2009，28（5）：480-485.

[46]Avlonitis VS，Wigfield CH，Golledge HD，et al.Early hemodynamic injury during donor brain death determines the severity of primary graft dysfunction after lung transplantation[J].Am J Transplant，2007，7（1）：83-90.

[47]Wheeldon DR，Potter CD，Oduro A，et al.Transforming the“unacceptable”donor：Outcomes from the adoption of a standardized donor management technique[J].J Heart Lung Transplant，1995，14（4）：734-742.[48]Salim A，Martin M，Brown C，et al.The effect of a protocol of aggressive donor management：Implications for the national organ donor shortage[J].J Trauma，2006，61（2）：429-433.

[49]Shemie SD，Doig C，Dickens B，et al.Severe brain injury to neurological determination of death：Canadian forum recommendations[J].CMAJ，2006，174（6）：S1-S13.

[50]Rosendale JD，Chabalewski FL，McBride MA，et al.Increased transplanted organs from the use of a standardized donor management protocol[J].Am J Transplant，2002，2（8）：761-768.

[51]Jenkins DH，Reilly PM，Schwab CW.Improving the approach to organ donation：a review[J].World J Surg，1999，23（7）：644-649.

[52]Lopez-Navidad A，Domingo P，Caballero F.Organ shortage：viability of potential organ donors and possible loss depend on health care workers who are responsible for the organ procurement program[J].Transplant Proc，1997，29（8）：3614-3616.

[53]Singbartl K，Murugan R，Kaynar AM，et al.Intensivist-led management of brain-dead donors is associated with an increase in organ recovery for transplantation[J].Am J Transplant，2011，11（7）：1517-1521.

[54]Wood RE.Donor management，multi organ procurement and renal preservation[J].J R Soc Med，1996，89（Suppl 29）：23-24.

[55]Avlonitis VS，Wigfield CH，Kirby JA，et al.The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor[J].Am J Transplant，2005，5（4 Pt 1）：684-693.

[56]Wood KE，Becker BN，McCartney JG，et al.Care of the potential organ donor[J].N Engl J Med，2004，351（26）：2730-2739.

[57]Salim A，Martin M，Brown C，et al.Complications of brain death：frequency and impact on organ retrieval[J].Am Surg，2006，72（5）：377-381.

[58]Boom H，Mallat MJ，de Fijter JW，et al.Calcium levels as a risk factor for delayed graft function[J].Transplantation，2004，77（6）：868-873.

[59]Cywinski JB，Mascha E，Miller C，et al.Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function[J].Liver Transpl，2008，14（1）：59-65.

[60]Zaroff JG，Rosengard BR，Armstrong WF，et al.Consensus conference report：maximizing use of organs recovered from the cadaver donor：cardiac recommendations：March 28-29，2001，Crystal City，Va[J].Circulation，2002，106（7）：836-841.

[61]Schnuelle P，Lorenz D，Mueller A，et al.Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation[J].Kidney Int，1999，56（2）：738-746.

[62]Schnuelle P，Berger S，de BJ，et al.Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation[J].Transplantation，2001，72（3）：455-463.

[63]Schnuelle P，Berger S，de BJ，et al.Donor employment of vasopressors and its impact on allograft survival after transplantation[J].Transplant Proc，2001，33（1-2）：1282-1283.

[64]Schnuelle P，Yard BA，Braun C，et al.Impact of donor dopamine on immediate graft function after kidney transplantation[J].Am J Transplant，2004，4（3）：419-426.

[65]Schnuelle P，Gottmann U，Hoeger S，et al.Effects of donor pretreatment with dopamine on graft function after kidney transplantation：a randomized controlled trial[J].JAMA，2009，302（10）：1067-1075.

[66]Stoica SC，Satchithananda DK，White PA，et al.Noradrenalin use in the human donor and relationship with load-independent right ventricular contractility[J].Transplantation，2004，78（8）：1193-1197.

[67]Kutsogiannis DJ，Pagliarello G，Doig C，et al.Medical management to optimize donor organ potential：review of the literature[J].Can J Anaesth，2006，53（8）：820-830.

[68]Pennefather SH，Bullock RE，Mantle D，et al.Use of low dose arginine vasopressin to support brain-dead organ donors[J].Transplantation，1995，59（1）：58-62.

[69]de PM，Weder W，Patterson GA，et al.Strategies to increase limited donor resources[J].Eur Respir J，2004，23（3）：477-482.

[70]Venkateswaran RV，Steeds RP，Quinn DW，et al.The haemodynamic effects of adjunctive hormone therapy in potential heart donors：a prospective randomized double-blind factorially designed controlled trial[J].Eur Heart J，2009，30（14）：1771-1780.

[71]McLean KM，Pandalai PK，Pearl JM，et al.Beta-adrenergic receptor antagonism preserves myocardiaI function after brain death in a porcine model[J].J Heart Lung Transplant，2007，26（5）：522-528.

[72]Audibert G，Charpentier C，Seguin-Devaux C，et al.Improvement of donor myocardial function after treatment of autonomic storm during brain death[J].Transplantation，2006，82（8）：1031-1036.

[73]Powner DJ，Crommett JW.Advanced assessment of hemodynamic parameters during donor care[J].Prog Transplant，2003，13（4）：249-257.

[74]Gu J，Tao G，Yi B，et al.Hemodynamic monitoring in pigs undergoing orthotopic abdominaI multivisceral transplantation[J].Transplant Proc，2009，41（10）：4376-4381.

[75]Dominguez-Roldan JM，Jimenez-Gonzalez PI，Garcia-Alfaro C，et al.Electrolytic disorders，hyperosmolar states，and lactic acidosis in braindead patients[J].Transplant Proc，2005，37（5）：1987-1989.

[76]Powner DJ，Allison TA.Cardiac dysrhythmias during donor care[J].Prog Transplant，2006，16（1）：74-80.

[77]Garcia-Fages LC，Cabrer C，Valero R，et al.Hemodynamic and metabolic effects of substitutive triiodothyronine therapy in organ donors[J].Transplant Proc，1993，25（6）：3038-3039.

[78]Novitzky D，Cooper DK，Human PA，et al.Triiodothyronine therapy for heart donor and recipient[J].J Heart Transplant，1988，7（5）：370-376.

[79]Novitzky D，Cooper DK，Chaffin JS，et al.Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient[J].Transplantation，1990，49（2）：311-316.

[80]Novitzky D，Matthews N，Shawley D，et al.Triiodothyronine in the recovery of stunned myocardium in dogs[J].Ann Thorac Surg，1991，51（1）：10-16.

[81]Rosendale JD，Kauffman HM，McBride MA，et al.Aggressive pharmacologic donor management results in more transplanted organs[J].Transplantaton，2003，75（4）：482-487.

[82]Salim A，Martin M，Brown C，et al.Using thyroid hormone in brain-dead donors to maximize the number of organs available for transplantation[J].Clin Transplant，2007，21（3）：405-409.

[83]Mckeown WD，Bonser SR，Kellum AJ.Management of the heartbeating brain-dead organ donor[J].BJA，2012，108（S1）：i96-i107.

[84]Dimopoulou I，Tsagarakis S，Anthi A，et al.High prevalence of decreased cortisol reserve in brain-dead potential organ donors[J].Crit Care Med，2003，31（4）：1113-1117.

[85]Blasi-Ibanez A，Hirose R，Feiner J，et al.Predictors associated with terminal renal function in deceased organ donors in the intensive care unit[J].Anesthesiology，2009，110（2）：333-341.

[86]Obermaier R，von DE，Keck T，et al.Brain death impairs pancreatic microcirculation[J].Am J Transplant，2004，4（2）：210-215.

[87]Mascia L，Bosma K，Pasero D，et al.Ventilatory and hemodynamic management of potential organ donors：an observational survey[J].Crit Care Med，2006，34（2）：321-327.

[88]Avlonitis VS，Fisher AJ，Kirby JA，et al.Pulmonary transplantation：the role of brain death in donor lung injury[J].Transplantation，2003，75（12）：1928-1933.

[89]Powner DJ，Darby JM，Stuart SA.Recommendations for mechanical ventilation during donor care[J].Prog Transplant，2000，10（1）：33-38.

[90]Follette DM，Rudich SM，Babcock WD.Improved oxygenation and increased lung donor recovery with highdose steroid administration after brain death[J].J Heart Lung Transplant，1998，17（4）：423-429.

[91]Gabbay E，Williams TJ，Griffiths AP，et al.Maximizing the utilization of donor organs offered for lung transplantation[J].Am J Respir Crit Care Med，1999，160（1）：265-271.

[92]Riou B，Guesde R，Jacquens Y，et al.Fiberoptic bronchoscopy in brain-dead organ donors[J].Am J Respir Crit Care Med，1994，150（2）：558-560.

[93]Mascia L，Pasero D，Slutsky AS，et al.Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation：a randomized controlled trial[J].JAMA，2010，304（23）：2620-2627.

[94]Levesque S，Lessard MR，Nicole PC，et al.Efficacy of a T-piece system and a continuous positive airway pressure system for apnea testing in the diagnosis of brain death[J].Crit Care Med，2006，34（8）：2213-2216.

[95]Powner DJ，Reich HS.Regulation of coagulation abnormalities and temperature in organ donors[J].Prog Transplant，2000，10（3）：146-151；quiz 152-153.

[96]Kutsogiannis DJ，Pagliarello G，Doig C，et al.Medical management to optimize donor organ potential：review of the literature[J].Can J Anesth，2006，53（8）：820-830.

[97]Grino JM，Miravitlles R，Castelao AM，et al.Flush solution with mannitol in the prevention of post-transplant renal failure[J].Transplant Proc，1987，19（5）：4140-4142.

[98]Haririan A，Metireddy M，Cangro C，et al.Association of serum uric acid with graft survival after kidney transplantation：a time-varying analysis[J].Am J Transplant，2011，11（9）：1943-1950.

[99]Khan TA，Schnickel G，Ross D，et al.A prospective，randomized，crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients[J].J Thorac Cardiovasc Surg，2009，138（6）：1417-1424.

[100]Singer P，Cohen J，Cynober L.Effect of nutritional state of brain-dead organ donor on transplantation[J].Nutrition，2001，17（11-12）：948-952.

[101]Barklin A.Systemic inflammation in the brain-dead organ donor[J].Acta Anaesthesiol Scand，2009，53（4）：425-435.

[102]Nijboer WN，Schuurs TA，van der Hoeven JA，et al.Effects of brain death on stress and inflammatory response in the human donor kidney[J].Transplant Proc，2005，37（1）：367-369.

[103]Lopau K，Mark J，Schramm L，et al.Hormonal changes in brain death and immune activation in the donor[J].Transp Int，2000，13（Suppl 1）：S282-S285.

[104]Kuecuek O，Mantouvalou L，Klemz R，et al.Significant reduction of proinflammatory cytokines by treatment of the brain-dead donor[J].Transplant Proc，2005，37（1）：387-388.

[105]Kotsch K，Ulrich F，Reutzel-Selke A，et al.Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation：a prospective randomized controlled trial[J].Ann Surg，2008，248（6）：1042-1050.

[106]Venkateswaran RV，Dronavalli V，Lambert PA，et al.The proinflammatory environment in potential heart and lung donors：prevalence and impact of donor management and hormonal therapy[J].Transplantation，2009，88（4）：582-588.

[107]Gelb AW，Robertson KM.Anaesthetic management of the brain dead for organ donation[J].Can J Anaesth，1990，37（7）：806-812.

[108]Walaszewski J，Rowinski W，Chmura A，et al.Decreased incidence of acute tubular necrosis after cadaveric donor transplantation due to lidocaine donor pretreatment and low-dose dopamine infusion in the recipient[J].Transplant Proc，1988，20（5）：913.

[109]Zych B，Popov AF，Stavri G，et al.Early outcomes of bilateral sequential single lung transplantation after exvivo lung evaluation and reconditioning[J].J Heart Lung Transplant，2012，31（3）：274-281.

[110]Vekemans K，van Pelt J，Komuta M，et al.Attempt to rescue discarded human liver grafts by end ischemic hypothermic oxygenated machine perfusion[J].Transplant Proc，2011，43（9）：3455-3459.

[111]Youn TS，Greer DM.Brain death and management of a potential organ donor in the intensive care unit[J].Critical care clinics，2014，30（4）：813-831.

[112]Lansdale M，Gropper MA.Management of the potential organ donor in the ICU[J].ICU Director，2012，3（4）：185-188.

原载于《中华移植杂志（电子版）》，2016，10（4）：145-153